BamSEC and AlphaSense Join Forces
Learn More

Astria Therapeutics Inc.

NASDAQ: ATXS    
Share price (1/8/25): $8.35    
Market cap (1/8/25): $471 million

Underwriting Agreements Filter

EX-1.1
from 8-K 39 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 42 pages 10,340,000 Shares of Common Stock Astria Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages 8,253,895 Shares of Common Stock Pre-Funded Warrants to Purchase 1,571,093 Shares of Common Stock and Common Stock Warrants to Purchase 7,368,738 Shares of Common Stock Astria Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 43 pages 9,082,653 Shares of Common Stock Astria Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 39 pages Open Market Sale Agreementsm
12/34/56
EX-1
from SC 13G/A ~1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 38 pages 4,600,000 Shares of Common Stock Catabasis Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-3 32 pages Catabasis Pharmaceuticals, Inc. $50,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 39 pages 4,000,000 Units, Each Consisting of One Share of Common Stock and 0.5 of a Warrant to Purchase One Share of Common Stock Catabasis Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages Catabasis Pharmaceuticals, Inc. $50,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 35 pages 42,000,000 Common Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock Catabasis Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 40 pages [·] Common Units, Each Consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock [·] Pre-Funded Units, Each Consisting of a Pre-Funded Warrant to Purchase One Share of Common Stock and a Warrant to Purchase One Share of Common Stock Catabasis Pharmaceuticals, Inc. Form of Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 34 pages Catabasis Pharmaceuticals, Inc. $10,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 31 pages Catabasis Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages Catabasis Pharmaceuticals, Inc. $10,000,000 Common Stock Sales Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 33 pages Catabasis Pharmaceuticals, Inc. Shares Common Stock ($0.001 Par Value Per Share) Underwriting Agreement
12/34/56